For this round of case based panel discussions, Dr. Jack West is joined by Drs. Jonathan Riess and Suki Padda.
Jonathan W. Riess, MD MS is Associate Professor of Medicine in the Division of Hematology/Oncology at UC Davis Comprehensive Cancer Center.
Sukhmani Padda MD is Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center.
The doctors discuss a series of cases related to a diagnosis of ALK Positive NSCLC. In this video, the discussion is regarding progression after success on an ALK inhibitor. Do you continue the ALK inhibitor when transitioning to a chemo based treatment?
For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.